Home / Medical Devices / Neurostimulation Devices Market By Type (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, Gastric Electric Stimulators), By Therapeutic Areas (Pain Management, Epilepsy, Essential Tremors, Urinary And Fecal Incontinence, Depression, Dystonia, Gastroparesis, Parkinson’s Disease) - Growth, Future Prospects & Competitive Analysis, 2016 - 2024

Neurostimulation Devices Market By Type (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, Gastric Electric Stimulators), By Therapeutic Areas (Pain Management, Epilepsy, Essential Tremors, Urinary And Fecal Incontinence, Depression, Dystonia, Gastroparesis, Parkinson’s Disease) - Growth, Future Prospects & Competitive Analysis, 2016 - 2024

Published: Jan 2017 | Report Code: 58336-01-17

Neurostimulation is the process of agitating or modulating the neural activities for therapeutic purpose. Neurostimulation devices are used for neuromodulation and function by either stimulating nerve impulses of inhibiting pain signals at specific sites such as the autonomic nervous system, peripheral nervous system, deep nuclei of brain or the central nervous system. Significant growth in geriatric population base has triggered the incidence of age related nervous conditions such as Alzheimer’s disease and Parkinson’s disease, and has thereby presented an area of high unmet medical needs in neurological disease segments. Similar scenario is also experienced in other conditions such as chronic pain, migraine, epilepsy and others. Going forward, it is expected that the growth of neurostimulation devices market will be facilitated by efficient harnessing of the untapped market opportunities in Asia Pacific and Latin America markets further evolution in neurostimulation treatments.

This report attempts to study the global neurostimulation devices market in terms of product types, therapeutic areas, and regional distribution. Based on product types, this report studies individual markets for spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator and gastric electric stimulator. Whereas, in terms of therapeutic areas, the report studies global neurostimulation devices market for pain management, epilepsy, essential tremor, urinary and fecal incontinence, depression, dystonia, gastroparesis, parkinson's disease and other therapeutic areas. Market size and forecast for each mentioned segment are provided in this report for the period 2013-2024 (US$ Mn), along with respective CAGR (value %) for the period 2016-2024.

Geographically, the neurostimulation devices market is studied for the following regional markets:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of LATAM
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East and Africa

Market size and respective forecast for these regional and country level markets are presented in this study for the period 2013-2024. Market growth rates for the forecast period 2016-2024 are also included in this report, considering 2015 as the base year. This study also includes cross-sectional market size and forecast for each regional market thus considered by product types, and therapeutic areas.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global neurostimulation devices market. Tools such as market positioning of key players, and attractive investment proposition provide the readers with insights on the competitive scenario of the global neurostimulation devices market. This report concludes with company profiles section that highlights major information about the key players engaged in development, manufacture and sales of neurostimulation devices.

Neurostimulation Devices Market

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Neurostimulation Devices Market Portraiture
2.2 Global Neurostimulation Devices Market (US$ Mn), by Type, 2015
2.3 Global Neurostimulation Devices Market (US$ Mn), by Therapeutic Area, 2015
2.4 Global Neurostimulation Devices Market Share (Value %), by Geography, 2015

Chapter 3 Global Neurostimulation Devices Market Overview
3.1 Overview
3.2 Market Dynamics
3.2.1 Drivers
3.2.2 Challenges
3.2.3 Opportunities
3.3 Attractive Investment Proposition
3.4 Market Competition Assessment: Neurostimulation Devices Market, by Key Players

Chapter 4 Global Neurostimulation Devices Market (US$ Mn), By Type, 2013-2024
4.1 Introduction
4.2 Spinal Cord Stimulators
4.3 Deep Brain Stimulators
4.4 Sacral Nerve Stimulators
4.5 Vagus Nerve Stimulators
4.6 Gastric Electric Stimulators

Chapter 5 Global Neurostimulation Devices Market (US$ Mn), By Therapeutic Areas, 2013-2024
5.1 Introduction
5.2 Pain Management
5.3 Epilepsy
5.4 Essential Tremors
5.5 Urinary and Fecal Incontinence
5.6 Depression
5.7 Dystonia
5.8 Gastroparesis
5.9 Parkinson’s Disease
5.10 Others

Chapter 6 Global Neurostimulation Devices Market (US$ Mn), By Geography, 2013-2024
6.1 Preface
6.2 North America (U.S., Canada)
6.3 Europe (U.K., Germany, Rest of Europe)
6.4 Asia Pacific (Japan, China, Rest of Asia Pacific)
6.5 Latin America (Brazil, Mexico, Rest of LATAM)
6.6 Middle East and Africa (Saudi Arabia, South Africa, Rest of MEA)

Chapter 7 Company Profiles
7.1 Medtronic
7.2 St. Jude Medical
7.3 Boston Scientific Corporation
7.4 Cyberonics
7.5 Nevro Corp
7.6 Cogentix Medical
7.7 Neuronetics, Inc.
7.8 IntraPace, Inc.
7.9 Codman & Shurtleff, Inc.
7.10 Other Notable Players

List Of Table :

TABLE 1 Global Neurostimulation Devices Market (US$ Mn), By Type, 2013-2024
TABLE 2 Global Neurostimulation Devices Market (US$ Mn), By Therapeutic Areas, 2013-2024
TABLE 3 Global Neurostimulation Devices Market (US$ Mn), by Geography, 2013–2024
TABLE 4 North America Neurostimulation Devices Market (US$ Mn), by Country, 2013–2024
TABLE 5 North America Neurostimulation Devices Market (US$ Mn), by Type, 2013–2024
TABLE 6 North America Neurostimulation Devices Market (US$ Mn), by Therapeutic Area, 2013–2024
TABLE 7 Europe Neurostimulation Devices Market, by Country, 2013–2024 (US$ Mn)
TABLE 8 Europe Neurostimulation Devices Market (US$ Mn), by Type, 2013–2024
TABLE 9 Europe Neurostimulation Devices Market (US$ Mn), by Therapeutic Area, 2013–2024
TABLE 10 Europe Neurostimulation Devices Market (US$ Mn), by Country, 2013–2024
TABLE 11 Asia Pacific Neurostimulation Devices Market (US$ Mn), by Type, 2013–2024
TABLE 12 Asia Pacific Neurostimulation Devices Market (US$ Mn), by Therapeutic Area, 2013–2024
TABLE 13 Latin America Neurostimulation Devices Market (US$ Mn), by Country, 2013–2024
TABLE 14 Latin America Neurostimulation Devices Market (US$ Mn), by Type, 2013–2024
TABLE 15 Latin America Neurostimulation Devices Market (US$ Mn), by Therapeutic Area, 2013–2024
TABLE 16 Middle East and Africa Neurostimulation Devices Market (US$ Mn), by Country, 2013–2024
TABLE 17 Middle East and Africa Neurostimulation Devices Market (US$ Mn), by Type, 2013–2024
TABLE 18 Middle East and Africa Neurostimulation Devices Market (US$ Mn), by Therapeutic Area, 2013–2024
TABLE 19 Medtronic: Company Snapshot (Business Description, Financial Information, Product Position and Portfolio, Recent Developments)
TABLE 20 St. Jude Medical: Company Snapshot (Business Description, Financial Information, Product Position and Portfolio, Recent Developments)
TABLE 21 Boston Scientific Corporation: Company Snapshot (Business Description, Financial Information, Product Position and Portfolio, Recent Developments)
TABLE 22 Cyberonics: Company Snapshot (Business Description, Financial Information, Product Position and Portfolio, Recent Developments)
TABLE 23 Nevro Corp: Company Snapshot (Business Description, Financial Information, Product Position and Portfolio, Recent Developments)
TABLE 24 Cogentix Medical: Company Snapshot (Business Description, Financial Information, Product Position and Portfolio, Recent Developments)
TABLE 25 Neuronetics, Inc.: Company Snapshot (Business Description, Financial Information, Product Position and Portfolio, Recent Developments)
TABLE 26 IntraPace, Inc.: Company Snapshot (Business Description, Financial Information, Product Position and Portfolio, Recent Developments)
TABLE 27 Codman & Shurtleff, Inc.: Company Snapshot (Business Description, Financial Information, Product Position and Portfolio, Recent Developments)

List Of Figure :

FIG. 1 Neurostimulation Devices Market: Research Methodology
FIG. 2 Global Neurostimulation Devices Market (US$ Mn), by Type, 2015
FIG. 3 Global Neurostimulation Devices Market (US$ Mn), by Therapeutic Area, 2015
FIG. 4 Global Neurostimulation Devices Market (Value %), by Geography, 2015
FIG. 5 Attractive Investment Proposition, by Geography, 2015
FIG. 6 Market Positioning of Key Neurostimulation Devices Companies, 2015
FIG. 7 Global Spinal Cord Stimulators Market (US$ Mn), 2013–2024
FIG. 8 Global Deep Brain Stimulators Market (US$ Mn), 2013–2024
FIG. 9 Global Sacral Nerve Stimulators Market (US$ Mn), 2013–2024
FIG. 10 Global Vagus Nerve Stimulators Market (US$ Mn), 2013–2024
FIG. 11 Global Gastric Electric Stimulators Market (US$ Mn), 2013–2024
FIG. 12 Global Neurostimulation Devices Market in Pain Management (US$ Mn), 2013–2024
FIG. 13 Global Neurostimulation Devices Market in Epilepsy Treatment (US$ Mn), 2013–2024
FIG. 14 Global Neurostimulation Devices Market in Essential Tremors Management (US$ Mn), 2013–2024
FIG. 15 Global Neurostimulation Devices Market in Urinary and Fecal Incontinence Treatment (US$ Mn), 2013–2024
FIG. 16 Global Neurostimulation Devices Market in Depression Treatment (US$ Mn), 2013–2024
FIG. 17 Global Neurostimulation Devices Market in Dystonia Treatment (US$ Mn), 2013–2024
FIG. 18 Global Neurostimulation Devices Market in Gastroparesis Treatment (US$ Mn), 2013–2024
FIG. 19 Global Neurostimulation Devices Market in Parkinson’s Disease Treatment (US$ Mn), 2013–2024
FIG. 20 Global Neurostimulation Devices Market in Other Therapeutic Areas (US$ Mn), 2013–2024

Based on the type therapeutic areas where neurostimulation is significantly in demand, the global neurostimulation devices market is segmented as follows:

  • Pain Management
  • Epilepsy
  • Essential Tremor
  • Urinary and Fecal Incontinence
  • Depression
  • Dystonia
  • Gastroparesis
  • Parkinson's Disease
  • Others

Neurostimulation Devices Market

Pain management is the mainstay of neurostimulation applications, highest prevalence of chronic pain, surgical pain and trauma related pain are the major therapeutic areas where neurostimulation devices are extensively used as adjunct to conventional medication administration. In addition, the market size of neurostimulation devices for treating Parkinson’s disease is expected to progress a an impressive growth rate due to large geriatric patient pool and proven efficiency of neurostimulation devices in treating neurological disorders. Other conditions such as migraine and epilepsy are observed to have high unmet needs in terms of efficient treatment. Such gaps between the disease prevalence and treatment efficiency essentially serve a lucrative market opportunities for neurostimulation devices market.

Based on the product types, the global neurostimulation devices market is segmented as follows:

  • Spinal Cord Stimulator
  • Deep Brain Stimulator
  • Sacral Nerve Stimulator
  • Vagus Nerve Stimulator
  • Gastric Electric Stimulator

Neurostimulation Devices Market

Spinal cord stimulation currently dominate the overall market in terms of revenue share and it is anticipate that the segment will retain its dominance through the forecast period. The lead of spinal cord stimulators is majorly attributed to the relatively larger application and patient base of spinal cord stimulation devices and extensive market penetration. Introduction of technologically advanced devices in this segment will further assist in market sustenance. Some of the recent technological advancements in this space are MRI safety enabled devices, tripolar leads etc. However, growing demand for sacral nerve stimulation devices and deep brain stimulators. Based on the same, it is anticipated that the revenue share of sacral nerve stimulators and deep brain stimulators will augment through the forecast period. In addition, the demand for gastric electric stimulators is also expected to further grow due to its expanding application areas such as its promising role in obesity control.

For the purpose of this study, the global neurostimulation devices market is categorized as follows:

  • North America (U.S., Canada)
  • Europe (U.K., Germany, Rest of Europe)
  • Asia Pacific (Japan, China, Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, Rest of Latin America)
  • Middle East and Africa (Saudi Arabia, South Africa, Rest of MEA)

Neurostimulation Devices Market

North America accounted for the largest revenue share in the global neurostimulation devices market. However, the region is expected to lose its market share to rapid developments in European and Asia Pacific markets, stringent regulatory policies in the U.S. and yet retain its dominance during the forecast period. In addition, presence of large unmet needs in Asia and Latin America will make the manufacturers to shift their focus from North America and Western Europe and allow the fastest market growth rates to these regions. Improving disposable incomes of the general population and awareness about availability of latest treatments for neurodegenerative diseases are anticipated to be chief environmental factors prevalent in the region. Existence of significantly large patient population base will also further drive the market growth in Asia Pacific.

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Credence Webinars

Join Credence analysts to explore the latest IT Trends

view upcoming webinars

Our Clients